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Background: Various types of gastro-intestinal complications have already
been reported after atrial fibrillation (AF) radiofrequency ablation. The objec-
tive of this prospective study was to assess the incidence of esogastric injuries
after pulmonary vein isolation (PVI) with the cryoballoon catheter (Arctic
Front, Cryocath, Quebec, Canada).
Methods: Between December 2007 and April 2009, 25 patients (15 males,
mean age 55 years old) with symptomatic, drug refractory, paroxysmal (n= 24)
or persistent (n= 1) AF underwent circumferential antral PVI using a cryobal-
loon catheter. Post-procedural upper gastro-intestinal endoscopy was system-
atically performed on the following day.
Results: All procedures were performed in patients using a double lumen
23 or 28 mm cryoballoon catheter, with a mean maximal temperature of – 45.5
± 19.7°C. Out of the 100 veins treated by the cryoballoon technique, 93 were
completely isolated (93%). The number of balloon applications per vein was
2.2 ± 0.7 and the mean procedure time was 158.5 ± 28.7 minutes. Endoscopy
found gastroparesia in 4 patients (16%, 2 gastric bezoar and 2 severe gastric
stasis) which were considered as likely related to the ablation and due to vagal
injury. All patients were asymptomatic. In 13 cases (52%), endoscopic abnor-
malities were considered as fortuitous (peptic gastritis and esophagitis, n=8;
gastric ulcer, n=1; hiatal hernia, n=5; esophageal lipoma, n=1). In one case,
the endoscopy revealed a Mallory Weiss syndrome, presumably connected to
pre-operative trans-esophageal echocardiography. Esograstric endoscopy was
normal in only 8 cases (32%).
Conclusion: Cryoballoon catheter ablation for AF is associated with an
unusual high incidence of gastroparesia (16%) which could be related to pro-
cedural periesophageal vagal nerve damage.
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Introduction: Although most ventricular tachycardia (VT) originates from
the endocardium, epicardial substrate requiring epicardial mapping/ablation is
increasingly recognized. There is, however, limited information about its
safety and mid-term complications.
Methods: All patients undergoing VT ablation in 3 tertiary care centers
between 2001 and 2007 were included in this study. Of 913 VT ablations, 156
procedures (17%) involved epicardial mapping and/or ablation. These were
performed in 134 patients (109 male, 56 ±15yo), after a previous VT ablation
in 119 (76%). The underlying substrate was ischemic cardiomyopathy (CMP)
in 51, non ischemic CMP in 39, Arrhythmogenic Right Ventricular Cardiomy-
opathy in 13, and others types of CMPs in 31.
Results: Epicardial access was obtained via percutaneous subxyphoid
puncture in 136 procedures, by a surgical subxyphoid approach in 14 and
during open heart surgery in 6. Epicardial ablation (13±12min; median:
10min) was performed in 121/156 procedures (78%). Nineteen patients subse-
quently required repeat procedure(s) and the epicardium could be re-accessed
in all but one patient.
A total of 8/156 (5 %) major complications related to pericardial access
were observed acutely: 7 epicardial bleeding (>100cc) [all bleeding stopped
spontaneously] and 1 coronary stenosis.
After a mean follow-up of 23±21months, 3 delayed complications related
to pericardial access, were noted (1 major pericardial inflammatory reaction, 1
delayed tamponade and 1 coronary occlusion 2 weeks after the procedure).
Conclusion: VT ablation requires epicardial mapping and ablation in 121/
913 (13%) procedures with a risk of 5% and 2% of acute and delayed major
complications related to epicardial access.
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Introduction: Ischemic stroke (IS) is a frequent pathology, burdened by
high rate of recurrence and significant morbidity and mortality. There are
several causes of IS, affecting prognosis, outcomes and management, but in
many cases the etiology remains undetermined despite comprehensive
research. We hypothezised that atrial fibrillation (AF) was largely involved
in this pathology but was underdiagnosed by standard methods. The aim of
this study was to determine the incidence of AF in cryptogenic IS, by using
continuous monitoring of the heart rate over several months. The secondary
objective was to test the predictive value of atrial vulnerability study towards
spontaneous AF.
Methods and results: We prospectively enrolled 24 patients under 75
years: 15 men and 9 women of mean age 48.8± 13.6 years who experi-
enced cryptogenic IS presumed of cardioembolic mechanism within the
last 4 months. Any cause of IS was excluded by normal 12-lead ECG, 24-
hour Holter monitoring, echocardiography, cervical Doppler, haematolog-
ical and inflammatory tests. All patients underwent electrophysiological
study. 7 patients (29.2%) had inducible arrhythmia during programmed
atrial stimulation and 9 (37.5%) had a latent vulnerability index (LVI)
<2.5. Patients were secondarily implanted with an implantable loop
recorder (ILR) (MedtronicTM Reveal Plus 9526) to look for spontaneous
AF over a mean follow-up interval of 14.5 months. No sustained
arrhythmia was found. Only one patient had non significant AF access
(<30 s). In this patient, it was not triggered sustained arrhythmia but the
LVI was low.
Conclusion: This study shows that contrary to what was expected, AF does
not appear to be a common pathology in patients under 75 years with unex-
plained IS. The use of ILR should not be generalized in the systematic assess-
ment of these patients because of its unprofitability. Finally this study attests
the poor value of atrial vulnerability study for predicting spontaneous AF in
such patients.
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